Inhaled triple therapy in chronic obstructive pulmonary disease - Authors' reply

Affiliations

¹ Respiratory Medicine, University of Ferrara, Ferrara 44121, Italy. Electronic address: ppa@unife.it.
² Division of Infection, Immunity, and Respiratory Medicine, University of Manchester, Manchester, UK.
³ Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy.

Comment

Alberto Papi et al. Lancet. 2018.

. 2018 Sep 29;392(10153):1113-1114.

doi: 10.1016/S0140-6736(18)31778-1.

¹ Respiratory Medicine, University of Ferrara, Ferrara 44121, Italy. Electronic address: ppa@unife.it.
² Division of Infection, Immunity, and Respiratory Medicine, University of Manchester, Manchester, UK.
³ Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy.

No abstract available

Comment on

An observational study of inhaled corticosteroid withdrawal in stable chronic obstructive pulmonary disease. ISOLDE Study Group.
Jarad NA, Wedzicha JA, Burge PS, Calverley PM. Jarad NA, et al. Respir Med. 1999 Mar;93(3):161-6. doi: 10.1016/s0954-6111(99)90001-x. Respir Med. 1999. PMID: 10464871 Clinical Trial.
Making Sense of Triple Inhaled Therapy for COPD.
Suissa S, Drazen JM. Suissa S, et al. N Engl J Med. 2018 May 3;378(18):1723-1724. doi: 10.1056/NEJMe1716802. Epub 2018 Apr 18. N Engl J Med. 2018. PMID: 29669218 No abstract available.